UTERINE CARCINOSARCOMA
Clinical trials for UTERINE CARCINOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new UTERINE CARCINOSARCOMA trials appear
Sign up with your email to follow new studies for UTERINE CARCINOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests an experimental oral drug called NKT5097 in adults with advanced solid tumors, especially breast cancer. The drug works by breaking down two proteins that help cancer cells grow. Researchers want to find the safest dose and see if it can shrink tumors…
Matched conditions: UTERINE CARCINOSARCOMA
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New hope for recurrent uterine cancer? drug combo enters early testing
Disease control Recruiting nowThis early-phase study tests a new drug called zanzalintinib combined with standard chemotherapy (paclitaxel) in people with recurrent high-grade uterine or endometrial cancer. The main goal is to find the safest and most effective dose of the combination. About 36 participants w…
Matched conditions: UTERINE CARCINOSARCOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New pill takes on tough cancers: early trial launches
Disease control Recruiting nowThis study tests a new daily pill, VLS-1488, for people with advanced solid tumors that have not responded to other treatments. About 200 participants with specific cancers like ovarian, lung, or breast cancer will receive the drug to see if it is safe and shrinks tumors. The goa…
Matched conditions: UTERINE CARCINOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Volastra Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New study aims to determine if less surgery is better for Early-Stage endometrial cancer
Knowledge-focused Recruiting nowThis study looks at whether removing only a few key lymph nodes (sentinel node biopsy) is better than removing no nodes at all in women with early-stage endometrial cancer. The goal is to see if this approach helps women return to normal activities faster and does not increase th…
Matched conditions: UTERINE CARCINOSARCOMA
Phase: PHASE3 • Sponsor: Queensland Centre for Gynaecological Cancer • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC